INVENT.INTEGRATE.INNOVATE. Trademark

Trademark Overview

On Wednesday, March 5, 2003, a trademark application was filed for INVENT.INTEGRATE.INNOVATE. with the United States Patent and Trademark Office. The USPTO has given the INVENT.INTEGRATE.INNOVATE. trademark a serial number of 78222130. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, December 19, 2007. This trademark is owned by Angiotech Pharmaceuticals, Inc.. The INVENT.INTEGRATE.INNOVATE. trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

research and development services in the field of pharmaceuticals and the biological sciences including drug delivery technology, medical devices, and surgical devices; research and development services in the field of pharmaceuticals and the biological sciences including drug delivery technology, medical devices, and surgical devices
invent.integrate.innovate.

General Information

Serial Number78222130
Word MarkINVENT.INTEGRATE.INNOVATE.
Filing DateWednesday, March 5, 2003
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, December 19, 2007
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesresearch and development services in the field of pharmaceuticals and the biological sciences including drug delivery technology, medical devices, and surgical devices; research and development services in the field of pharmaceuticals and the biological sciences including drug delivery technology, medical devices, and surgical devices
Pseudo MarkINVENTION INTEGRATE INNOVATE

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 28, 2003
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAngiotech Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver V6A 1B6

Trademark Events

Event DateEvent Description
Wednesday, December 19, 2007ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, December 19, 2007ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 22, 2007INQUIRY TO SUSPENSION E-MAILED
Tuesday, May 22, 2007SUSPENSION INQUIRY WRITTEN
Monday, April 9, 2007LIE CHECKED SUSP - TO ATTY FOR ACTION
Monday, April 9, 2007ASSIGNED TO LIE
Tuesday, October 24, 2006TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 19, 2006LETTER OF SUSPENSION E-MAILED
Tuesday, September 19, 2006SUSPENSION LETTER WRITTEN
Thursday, August 31, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 22, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 22, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, February 25, 2006INQUIRY TO SUSPENSION E-MAILED
Saturday, February 25, 2006SUSPENSION INQUIRY WRITTEN
Friday, September 16, 2005LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, February 25, 2005REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, October 27, 2004LIE CHECKED SUSP - TO ATTY FOR ACTION
Wednesday, September 8, 2004REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 23, 2004UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, February 23, 2004TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 18, 2003LETTER OF SUSPENSION E-MAILED
Monday, August 18, 2003ASSIGNED TO EXAMINER

Related Keywords

innovate integrate invent devices delivery drug technology medical surgical including sciences services development